N. Chiba

Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis

T. Yamaoka, F. Nishikaku, T. Noguchi, 2008, Cancer Chemotherapy and Pharmacology.

Immune response against cell-wall skeleton of Mycobacterium bovis BCG at the inoculation site and peripheral lymphoid organs.

I. Azuma, Y. Kashiwazaki, M. Murata, 2008, Drug discoveries & therapeutics.

Injection of cell-wall skeleton of Mycobacterium bovis BCG draining to a sentinel lymph node eliminates both lymph node metastases and the primary transplanted tumor.

I. Azuma, Y. Kashiwazaki, T. Sato, 2008, Drug discoveries & therapeutics.

Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.

Y. Kashiwazaki, T. Sato, M. Murata, 2012, Drug discoveries & therapeutics.

A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.

T. Kudo, Y. Katayose, S. Matsuno, 1996, The Tohoku journal of experimental medicine.